EGFR and neoplasm: In lung cancer cells, inhibition of SCD activity by CVT-11127 impairs phosphorylation of EGFR, resulting in inactivation of downstream targets Akt and ERK, effectively controlling metabolism, proliferation, and survival of tumor cells [204].